TIL-Driven De-escalated Chemotherapy in Stage I-II TNBC

NCT07074106 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Carboplatin and a Taxane

Sponsor

D'Or Institute for Research and Education

Collaborators

[object Object]